Physician

Christopher Roy Stelton, MD

According to 2025 Medicare claims, Christopher Stelton, MD (NPI: 1013234624) practices ophthalmology in the North Port-Bradenton-Sarasota, FL market, with the plurality of this provider's patient population coming from Sarasota, FL. This provider's primary affiliated billing organization is SK RETINA LLC (NPI: 1194170779; TIN: 474687611) and primary practice location at 34239-3110. Stelton is affiliated with the Emory Healthcare Network Advantage (ACO ID: A4771), participating under the MSSP model.

Stelton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,113 traditional Medicare patients, billed 1,102,126 HCPCS/CPT codes, and received $5,241,814 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 2,424 prescription claims across 693 beneficiaries totaling $162,488 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 7 records totaling $175. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $20,524 to $5,241,814. Similarly, Part D prescription costs have moved sharply higher in recent years, from $50,428 to $162,488. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.2M2015 Medicare payment: $20,524 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $15,968 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $275,045 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $630,246 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,462,292 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,546,991 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,711,050 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,445,385 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,223,394 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,241,814 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015146245$20,524
201687206$15,968
20173541,902$275,045
20186314,125$630,246
20191,1278,476$1,462,292
20201,0578,352$1,546,991
20211,1459,447$1,711,050
20222,02925,260$3,445,385
20232,120257,232$4,223,394
20242,1131,102,126$5,241,814

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$82K$164K2015 Drug cost: $50,428 (USD; Tot_Drug_Cst)2016 Drug cost: $16,118 (USD; Tot_Drug_Cst)2017 Drug cost: $10,745 (USD; Tot_Drug_Cst)2018 Drug cost: $25,495 (USD; Tot_Drug_Cst)2019 Drug cost: $47,695 (USD; Tot_Drug_Cst)2020 Drug cost: $54,180 (USD; Tot_Drug_Cst)2021 Drug cost: $86,459 (USD; Tot_Drug_Cst)2022 Drug cost: $139,480 (USD; Tot_Drug_Cst)2023 Drug cost: $164,264 (USD; Tot_Drug_Cst)2024 Drug cost: $162,488 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015232805$50,428
2016119375$16,118
201785243$10,745
201896293$25,495
2019198543$47,695
2020236661$54,180
2021300983$86,459
20224731,605$139,480
20235321,882$164,264
20246932,424$162,488

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system393393$106
67028Injection of drug into eye5442,404$93
92014Established patient complete exam of visual system1,4162,064$86
92012Established patient problem focused exam of visual system5871,660$67
92134Imaging of retina1,9954,628$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine261,530$32,012
VyzultaLatanoprostene Bunod301,049$13,579
Alphagan PBrimonidine Tartrate341,597$12,467
Prednisolone AcetatePrednisolone Acetate31112,813$10,736
LumiganBimatoprost281,014$9,960

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$175ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Christopher Roy Stelton, MD?

Tedicare shows public-source Medicare data for Christopher Roy Stelton, MD (NPI 1013234624), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Roy Stelton, MD have ACO affiliation data?

Christopher Roy Stelton, MD is shown with ACO affiliation data for Emory Healthcare Network Advantage (MSSP, ACO ID A4771).

What billing organization is linked to Christopher Roy Stelton, MD?

Christopher Roy Stelton, MD is linked to SK RETINA LLC (billing NPI 1194170779) in the available physician profile data.

Does Christopher Roy Stelton, MD have Open Payments data?

Christopher Roy Stelton, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.